Shanghai Hengrui Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SHANGHAI HENGRUI, and what generic and branded alternatives to SHANGHAI HENGRUI drugs are available?
SHANGHAI HENGRUI has two approved drugs.
Drugs and US Patents for Shanghai Hengrui
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shanghai Hengrui | DESFLURANE | desflurane | LIQUID;INHALATION | 208234-001 | Feb 26, 2018 | AN | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Shanghai Hengrui | SEVOFLURANE | sevoflurane | LIQUID;INHALATION | 203793-001 | Nov 3, 2015 | AN | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.